Oncomatryx Biopharma S.L.
2 clinical trials · Sponsor
◉ Watch Oncomatryx Biopharma S.L.
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma (NCT07377045) | Oncomatryx Biopharma S.L. | 2025-10-28 |
| Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. (NCT05547321) | Oncomatryx Biopharma S.L. | 2022-10-20 |
Track Oncomatryx Biopharma S.L. automatically
Every clearance here is in the API, with alerts when new ones post.